★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Becton, Dickinson and Company vs West Pharmaceutical Services, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Becton, Dickinson and Company

BDX · New York Stock Exchange

Market cap (USD)$54.8B
Gross margin (TTM)46.1%
Operating margin (TTM)9.8%
Net margin (TTM)4.5%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
Data as of2026-07-12
Moat score
65/ 100

Partial score covering 71% of segment weight.

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Becton, Dickinson and Company's moat claims, evidence, and risks.

View BDX analysis

West Pharmaceutical Services, Inc.

WST · New York Stock Exchange

Market cap (USD)$24.9B
Gross margin (TTM)36.8%
Operating margin (TTM)20.6%
Net margin (TTM)17%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
Data as of2026-08-09
Moat score
91/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into West Pharmaceutical Services, Inc.'s moat claims, evidence, and risks.

View WST analysis

Comparison highlights

  • Segment focus: Becton, Dickinson and Company has 4 segments (35.2% in Medical Essentials); West Pharmaceutical Services, Inc. has 2 segments (82.8% in Proprietary Products).
  • Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Moderate.
  • Moat breadth: Becton, Dickinson and Company has 5 moat types across 2 domains; West Pharmaceutical Services, Inc. has 2 across 2.

Primary market context

Becton, Dickinson and Company

Medical Essentials

Market

Single-use medical consumables and specimen collection systems

Geography

Global

Customer

Healthcare providers and clinical labs

Role

Manufacturer

Revenue share

35.2%

West Pharmaceutical Services, Inc.

Proprietary Products

Market

Injectable primary packaging components and containment/delivery systems (elastomeric stoppers, seals, plungers, syringe/cartridge components; related services)

Geography

Global

Customer

Biologic, generic, and pharmaceutical drug manufacturers

Role

Primary packaging and delivery component supplier

Revenue share

82.8%

Side-by-side metrics

Becton, Dickinson and Company
West Pharmaceutical Services, Inc.
Ticker / Exchange
BDX - New York Stock Exchange
WST - New York Stock Exchange
Market cap (USD)
$54.8B
$24.9B
Gross margin (TTM)
46.1%
36.8%
Operating margin (TTM)
9.8%
20.6%
Net margin (TTM)
4.5%
17%
Sector
Healthcare
Healthcare
Industry
Medical - Instruments & Supplies
Medical - Instruments & Supplies
HQ country
US
US
Primary segment
Medical Essentials
Proprietary Products
Market structure
Competitive
Oligopoly
Market share
n/a
70%-75% (reported)
HHI estimate
n/a
n/a
Pricing power
Weak
Moderate
Moat score
65 / 100 (partial, 71% coverage)
91 / 100
Moat domains
Supply, Demand
Demand, Supply
Last update
2026-07-12
2026-08-09

Moat coverage

Shared moat types

Design In Qualification

Becton, Dickinson and Company strengths

Operational ExcellenceData Workflow LockinInstalled Base ConsumablesLong Term Contracts

West Pharmaceutical Services, Inc. strengths

Capex Knowhow Scale

Segment mix

Becton, Dickinson and Company segments

Full profile >

Medical Essentials

Competitive

35.2%

Connected Care

Oligopoly

24.5%

BioPharma Systems

Oligopoly

11.1%

Interventional

Competitive

29.2%

West Pharmaceutical Services, Inc. segments

Full profile >

Proprietary Products

Oligopoly

82.8%

West Vantage

Competitive

17.2%

Act on this comparison

Turn a two-stock debate into a systemSee the systematic rankings that surface stocks like BDX and WST, with backtests and current holdings.

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.